A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina
- 1 October 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (8) , 43P-49P
- https://doi.org/10.1016/s0002-9149(98)00766-8
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Direct thrombin inhibitors in cardiovascular diseaseCoronary Artery Disease, 1997
- Predicting the risk of abrupt vessel closure after angioplasty in an individual patientJournal of the American College of Cardiology, 1994
- Usefulness and tolerability of Hirulog, a direct thrombin-inhibitor, in unstable angina pectorisThe American Journal of Cardiology, 1993
- Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable anginaThe American Journal of Cardiology, 1993
- Anticoagulant effects of hirulog, ∗∗Hirulog™ brand direct thrombin inhibitor. a novel thrombin inhibitor, in patients with coronary artery diseaseThe American Journal of Cardiology, 1993
- The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1992
- Lesion morphology and coronary angioplasty: Current experience and analysisJournal of the American College of Cardiology, 1992
- Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profileJournal of the American College of Cardiology, 1992
- In vivo thrombus formation on a guidewire during intravascular ultrasound imaging: Evidence for inadequate heparinizationCatheterization and Cardiovascular Diagnosis, 1991
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990